SOP Guide for Pharma

Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0

Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0

SOP for Residual Solvent Estimation Using HPLC in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/080/2025
Supersedes SOP/AMD/080/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the procedure for the development of an HPLC method for the estimation of residual solvents in active pharmaceutical ingredients (APIs) and drug products. The method aims

to identify and quantify Class 2 solvents as per ICH Q3C guidelines.

2. Scope

This procedure is applicable to the Analytical Method Development (AMD) department for the analysis of residual solvents in raw materials, APIs, intermediates, and finished dosage forms where gas chromatography (GC) is not feasible or practical.

3. Responsibilities

  • Analytical Chemist: Executes method development, prepares standard and test samples, performs injections, and evaluates results.
  • Reviewer: Reviews system suitability, linearity, detection limits, and confirms recovery accuracy.
  • QA Officer: Ensures documentation is complete and method complies with ICH Q3C and regulatory expectations.
  • Head – AMD: Reviews and approves the method for validation and routine analysis.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the residual solvent method developed by HPLC is scientifically justified, validated, and suitable for regulatory filing.

5. Procedure

5.1 Pre-Development Considerations

  1. List likely residual solvents based on manufacturing history or ICH Q3C classification (Class 1, 2, 3).
  2. Assess solvent UV absorbance properties. HPLC estimation is suitable for UV-active or derivatized solvents.
  3. Document solvent list in Annexure-1: Solvent Risk Assessment Sheet.

5.2 HPLC Method Setup

  1. Column: C18, 250 mm × 4.6 mm, 5 µm
  2. Mobile Phase: Water:Acetonitrile (50:50) or buffer-based if necessary
  3. Detection: UV at 210–220 nm or refractive index detector if available
  4. Flow Rate: 1.0 mL/min
  5. Injection Volume: 20 µL
  6. Record in Annexure-2: HPLC Setup Log

5.3 Standard and Sample Preparation

  1. Standard: Prepare individual solvent solutions and a mixed standard at relevant ICH Q3C concentration limits (e.g., 5000 ppm for Class 2 solvents).
  2. Sample: Weigh suitable amount of API or formulation (e.g., 100 mg) and dissolve in diluent (water/MeOH or DMF).
  3. Filter all solutions with 0.45 µm filter and transfer to HPLC vials.
  4. Document in Annexure-3: Sample and Standard Preparation Log

5.4 System Suitability and Linearity

  1. Inject blank, individual solvents, mixed standard, and test samples.
  2. System Suitability:
    • RSD of replicate standard injections ≤ 2.0%
    • Resolution between closest eluting solvents ≥ 1.5
  3. Linearity range: LOQ to 120% of specification limit (e.g., 1000–6000 ppm).
  4. R² ≥ 0.999 required for each solvent.
  5. Record in Annexure-4: System Suitability and Linearity Log

5.5 Accuracy and Recovery

  1. Spike blank matrix with known solvent quantities at 50%, 100%, and 150% levels.
  2. Calculate % recovery:

    % Recovery = (Recovered Concentration / Spiked Concentration) × 100
  3. Acceptance criteria: 85%–115% recovery
  4. Document in Annexure-5: Recovery Study Summary

5.6 LOD and LOQ Determination

  1. Inject decreasing concentrations of solvent until S/N ≥ 3 (LOD) and ≥ 10 (LOQ) is achieved.
  2. Inject six replicates at LOQ level and ensure %RSD ≤ 10%
  3. Document in Annexure-6: LOD and LOQ Summary

5.7 Sample Analysis and Reporting

  1. Inject sample solution in duplicate.
  2. Quantify solvent content using calibration curve or response factor.
  3. Ensure results meet the ICH Q3C limits for respective solvents.
  4. Summarize results in Annexure-7: Residual Solvent Analysis Report

6. Abbreviations

  • HPLC: High-Performance Liquid Chromatography
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • ppm: Parts Per Million
  • SOP: Standard Operating Procedure

7. Documents

  1. Solvent Risk Assessment Sheet – Annexure-1
  2. HPLC Setup Log – Annexure-2
  3. Sample and Standard Preparation Log – Annexure-3
  4. System Suitability and Linearity Log – Annexure-4
  5. Recovery Study Summary – Annexure-5
  6. LOD and LOQ Summary – Annexure-6
  7. Residual Solvent Analysis Report – Annexure-7

8. References

  • ICH Q3C (R8) – Impurities: Guideline for Residual Solvents
  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <467> – Residual Solvents
  • USP <621> – Chromatography

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Solvent Risk Assessment Sheet

Solvent Class Limit (ppm) Likely Source
Methanol Class 2 3000 API synthesis
Toluene Class 2 890 Crystallization

Annexure-2: HPLC Setup Log

Column Mobile Phase Detector λ Flow Rate
C18 Water:ACN (50:50) UV 210 nm 1.0 mL/min

Annexure-3: Sample and Standard Preparation Log

ID Type Concentration Diluent Prepared By
STD-Mix Standard 5000 ppm MeOH Rajesh Kumar

Annexure-4: System Suitability and Linearity Log

Parameter Observed Specification Status
RSD (n=5) 1.1% ≤ 2.0% Pass

Annexure-5: Recovery Study Summary

Spike Level Theoretical (ppm) Recovered (ppm) % Recovery
100% 5000 4962 99.2%

Annexure-6: LOD and LOQ Summary

Solvent LOD (ppm) LOQ (ppm) RSD @ LOQ
Toluene 5 15 6.8%

Annexure-7: Residual Solvent Analysis Report

Sample ID Solvent Result (ppm) Limit (ppm) Status
API-2025-01 Toluene 832 890 Complies

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included recovery, LOD/LOQ annexures and risk classification table Annual SOP Review
Exit mobile version